Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S W Hansen

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Pharmacoeconomics|July 6, 1997
Comments on economic evaluation of chemotherapyS R Clausen, V Jøjnsson, M M Hansen, et al.
Bone Marrow Transplantation|September 1, 1992
Increased yield of myeloid progenitor cells in bone marrow harvested for autologous transplantation by pretreatment with recombinant human granulocyte-colony stimulating factorH E Johnsen, P B Hansen, T Plesner, et al.
Leukemia|December 1, 1993
Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen seriesJ Pedersen-Bjergaard, P Philip, S O Larsen, et al.
Bone Marrow Transplantation|January 11, 2000
Selective loss of progenitor subsets following clinical CD34+ cell enrichment by magnetic field, magnetic beads or chromatography separationH E Johnsen, M Hutchings, E Taaning, et al.
Seminars in Oncology|November 5, 1997
Paclitaxel (175 mg/m2 over 3 hours) with cisplatin or carboplatin in previously untreated ovarian cancer: an interim analysisJ P Neijt, S A Engelholm, P O Witteveen, et al.
Bone Marrow Transplantation|February 16, 2000
Highly purified CD34+ cells isolated using magnetically activated cell selection provide rapid engraftment following high-dose chemotherapy in breast cancer patientsD J Richel, H E Johnsen, J Canon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2000
Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III studyH von der Maase, S W Hansen, J T Roberts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 7, 2023
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III StudyH von der Maase, S W Hansen, J T Roberts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1999
Advanced epithelial ovarian cancer: 1998 consensus statementsJ S Berek, K Bertelsen, A du Bois, et al.
Gynecologie, Obstetrique & Fertilite|September 21, 2000
[Epithelial ovarian cancer (advanced stage): consensus conference (1998)]J S Berek, K Bertelsen, A du Bois, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Pharmacoeconomics|July 6, 1997
Comments on economic evaluation of chemotherapyS R Clausen, V Jøjnsson, M M Hansen, et al.
Bone Marrow Transplantation|September 1, 1992
Increased yield of myeloid progenitor cells in bone marrow harvested for autologous transplantation by pretreatment with recombinant human granulocyte-colony stimulating factorH E Johnsen, P B Hansen, T Plesner, et al.
Leukemia|December 1, 1993
Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen seriesJ Pedersen-Bjergaard, P Philip, S O Larsen, et al.
Bone Marrow Transplantation|January 11, 2000
Selective loss of progenitor subsets following clinical CD34+ cell enrichment by magnetic field, magnetic beads or chromatography separationH E Johnsen, M Hutchings, E Taaning, et al.
Seminars in Oncology|November 5, 1997
Paclitaxel (175 mg/m2 over 3 hours) with cisplatin or carboplatin in previously untreated ovarian cancer: an interim analysisJ P Neijt, S A Engelholm, P O Witteveen, et al.
Bone Marrow Transplantation|February 16, 2000
Highly purified CD34+ cells isolated using magnetically activated cell selection provide rapid engraftment following high-dose chemotherapy in breast cancer patientsD J Richel, H E Johnsen, J Canon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2000
Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III studyH von der Maase, S W Hansen, J T Roberts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 7, 2023
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III StudyH von der Maase, S W Hansen, J T Roberts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1999
Advanced epithelial ovarian cancer: 1998 consensus statementsJ S Berek, K Bertelsen, A du Bois, et al.
Gynecologie, Obstetrique & Fertilite|September 21, 2000
[Epithelial ovarian cancer (advanced stage): consensus conference (1998)]J S Berek, K Bertelsen, A du Bois, et al.
Pageof 6